Business
OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers
MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its bas
About this update from Onemednet Corp
[{"type":"image","alt":"OneMedNet Corporation","displaySize":"","headline":null,"caption":"OneMedNet Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":288,"height":117,"url":"https://media.zenfs.com/en/globenewswire.com/513a33742df6a2a84791e6f654a8cce2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2hbxIN4EykXt6moj0t_15Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE3MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/513a33742df6a2a84791e6f654a8cce2","width":288,"height":117}},"lazy":false},{"type":"text","content":"MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet’s continued focus on expanding its base of subscription contracts, adding multi-year agreements that represent millions of dollars in incremental recurring revenue.","length":626,"tagName":"p"},{"type":"text","content":"The agreement was executed in record time following the companies’ initial meeting, reflecting strong commercial alignment, clear product-market fit, and immediate value to the customer. Data delivery is now underway and will be continuously delivered over a three-month project under a licensing agreement, delivering diverse multimodal data at scale. The speed of execution underscores the value Risorius placed on OneMedNet’s regulatory-grade data assets and delivery model.","length":477,"tagName":"p"},{"type":"text","content":"Under the agreement, Risorius has licensed access to large-scale electroencephalography (EEG) and polysomnography (PSG) waveform data paired with clinically meaningful context and longitudinal follow-up. The datasets will support internal R&D, model development, and validation efforts, including the advancement of EEG-based digital biomarkers and an AI Co-Scientist platform designed to support neurological and psychiatric clinical studies, especially for pharmaceutical companies and academic hospitals.","length":511,"tagName":"p"},{"type":"text","content":"Risorius selected OneMedNet based on the strong fit fo...